Stefan Dübel
#66,275
Most Influential Person Now
German biologist
Stefan Dübel's AcademicInfluence.com Rankings
Stefan Dübelbiology Degrees
Biology
#2978
World Rank
#4627
Historical Rank
Biotechnology
#200
World Rank
#202
Historical Rank
Molecular Biology
#526
World Rank
#539
Historical Rank
Biochemistry
#2436
World Rank
#2591
Historical Rank
Download Badge
Biology
Stefan Dübel's Degrees
- PhD Biology University of Cologne
Why Is Stefan Dübel Influential?
(Suggest an Edit or Addition)According to Wikipedia, Stefan Dübel is a German biologist. Since October 2002, he has been a full professor at the University of Braunschweig and head of the Biotechnology Department of the Institute of Biochemistry, Biotechnology and Bioinformatics. His work is centred around protein engineering, phage display and recombinant antibodies.
Stefan Dübel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Beyond natural antibodies: the power of in vitro display technologies (2011) (471)
- A helper phage to improve single-chain antibody presentation in phage display (2001) (280)
- A surface expression vector for antibody screening. (1991) (277)
- ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome (2007) (241)
- Antibody Engineering (2010) (169)
- A human scFv antibody generation pipeline for proteome research. (2011) (134)
- Mating antibody phage display with proteomics. (2004) (131)
- Single chain Fab (scFab) fragment (2007) (124)
- The translocon protein Sec61 mediates antigen transport from endosomes in the cytosol for cross-presentation to CD8(+) T cells. (2015) (122)
- Targeting Recombinant Antibodies to the Surface of Escherichia coli: Fusion to a Peptidoglycan Associated Lipoprotein (1991) (118)
- Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv). (1995) (108)
- High-Affinity, Human Antibody-Like Antibody Fragment (Single-Chain Variable Fragment) Neutralizing the Lethal Factor (LF) of Bacillus anthracis by Inhibiting Protective Antigen-LF Complex Formation (2007) (104)
- Generating recombinant antibodies to the complete human proteome. (2010) (102)
- The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody. (1997) (99)
- Generation and analysis of the improved human HAL9/10 antibody phage display libraries (2015) (97)
- Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes. (1996) (96)
- A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies. (2007) (95)
- Production systems for recombinant antibodies. (2008) (92)
- On the influence of vector design on antibody phage display. (2007) (92)
- Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies. (1994) (92)
- Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion. (1996) (92)
- Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes. (1995) (91)
- Phage display derived therapeutic antibodies. (2008) (88)
- Identification of Epitope Regions Recognized by Tumor Inhibitory and Stimulatory Anti-ErbB-2 Monoclonal Antibodies: Implications for Vaccine Design1 (2001) (82)
- Functional Characterization of Recombinant Chloroplast Signal Recognition Particle* (2001) (81)
- Measuring biomolecular binding events with a compact disc player device. (2005) (80)
- Differentiation pathways of ectodermal epithelial cells in hydra. (1987) (79)
- Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity (2009) (78)
- Effects of unpaired cysteines on yield, solubility and activity of different recombinant antibody constructs expressed in E. coli. (2000) (78)
- The influence of antibody fragment format on phage display based affinity maturation of IgG (2013) (76)
- Specific in vivo knockdown of protein function by intrabodies (2015) (76)
- Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV) (2008) (76)
- Perspectives for systematic in vitro antibody generation. (2005) (75)
- SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coli. (2008) (72)
- A family of vectors for surface display and production of antibodies. (1993) (72)
- NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases (2013) (72)
- Designing Human Antibodies by Phage Display (2017) (71)
- Recombinant antibodies and in vitro selection technologies. (2012) (70)
- Rise and Fall of an Anti-MUC1 Specific Antibody (2011) (68)
- Bacterial surface presentation of proteins and peptides: an alternative to phage technology? (1993) (68)
- Human antibody RNase fusion protein targeting CD30+ lymphomas. (2008) (67)
- Delivery of antibodies to the cytosol (2014) (66)
- Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus (2009) (65)
- Simultaneous mutagenesis of antibody CDR regions by overlap extension and PCR. (1994) (65)
- Isolation of IgG antibody Fv-DNA from various mouse and rat hybridoma cell lines using the polymerase chain reaction with a simple set of primers. (1994) (64)
- Role of the neuropeptide head activator for growth and development in hydra and mammals. (1989) (64)
- cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. (2003) (64)
- Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. (2001) (63)
- When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions (2018) (63)
- Recombinant therapeutic antibodies (2007) (63)
- Affinity maturation by phage display. (2009) (63)
- Towards proteome scale antibody selections using phage display. (2010) (61)
- A multi-Fc-species system for recombinant antibody production (2009) (59)
- Parameters affecting the display of antibodies on phage. (2005) (58)
- Identification of Immunogenic Antigens from Aspergillus fumigatus by Direct Multiparameter Characterization of Specific Conventional and Regulatory CD4+ T Cells (2014) (56)
- SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface (2020) (55)
- Analysis of IgG heavy chain to light chain ratio with mutant Encephalomyocarditis virus internal ribosome entry site. (2007) (52)
- Cloning and cytotoxicity of a human pancreatic RNase immunofusion. (1997) (51)
- Production of recombinant antibody fragments in Bacillus megaterium (2007) (51)
- Determination of phage antibody affinities to antigen by a microbalance sensor system. (1999) (51)
- Minimum information about a protein affinity reagent (MIAPAR) (2010) (50)
- Phage display vectors for the in vitro generation of human antibody fragments. (2005) (50)
- Improved microtitre plate production of single chain Fv fragments in Escherichia coli. (2009) (50)
- A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations (2021) (48)
- Enrichment of open reading frames presented on bacteriophage M13 using hyperphage. (2006) (48)
- Pacemaker activity and ionic currents in mouse atrioventricular node cells (2011) (48)
- Antibodies inside of a cell can change its outside: Can intrabodies provide a new therapeutic paradigm? (2016) (47)
- Cell-free synthesis of functional antibodies using a coupled in vitro transcription-translation system based on CHO cell lysates (2017) (46)
- The INNs and outs of antibody nonproprietary names (2015) (46)
- Efficient production of soluble recombinant single chain Fv fragments by a Pseudomonas putida strain KT2440 cell factory (2011) (45)
- Expression of a bispecific dsFv-dsFv' antibody fragment in Escherichia coli. (2000) (45)
- A Community Standard Format for the Representation of Protein Affinity Reagents* (2009) (42)
- Human antibodies neutralizing diphtheria toxin in vitro and in vivo (2020) (40)
- Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments (2014) (39)
- Terminal differentiation of ectodermal epithelial stem cells of Hydra can occur in G2 without requiring mitosis or S phase (1990) (39)
- A vector for the removal of deletion mutants from antibody libraries. (1992) (39)
- Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo (2012) (39)
- Epitope structures recognised by antibodies against the major coat protein (g8p) of filamentous bacteriophage fd (Inoviridae). (1999) (37)
- Animal-free alternatives and the antibody iceberg (2020) (37)
- Cloning single-chain antibody fragments (scFv) from hybridoma cells. (2004) (37)
- Identification of immunogenic proteins and generation of antibodies against Salmonella Typhimurium using phage display (2012) (34)
- Selection of recombinant antibodies from antibody gene libraries. (2007) (34)
- Single amino acid fingerprinting of the human antibody repertoire with high density peptide arrays. (2017) (32)
- Single-chain antibody streptavidin fusions: tetrameric bifunctional scFv-complexes with biotin binding activity and enhanced affinity to antigen. (1995) (31)
- Targeted therapeutic RNases (ImmunoRNases) (2009) (31)
- Multimerization domains for antibody phage display and antibody production. (2009) (31)
- Characterization of the epitope recognized by a monoclonal antibody directed against the largest subunit of Drosophila RNA polymerase II. (1995) (31)
- Separation of E. coli expressing functional cell-wall bound antibody fragments by FACS. (1996) (31)
- Cell differentiation in the head of Hydra (1989) (30)
- V-gene amplification revisited - An optimised procedure for amplification of rearranged human antibody genes of different isotypes. (2010) (30)
- Isolation of scFv fragments specific to OmpD of Salmonella Typhimurium. (2011) (29)
- Design, construction, and in vitro analysis of A33scFv::CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer. (2007) (29)
- A TNF receptor antagonistic scFv, which is not secreted in mammalian cells, is expressed as a soluble mono- and bivalent scFv derivative in insect cells. (1997) (29)
- Ribonucleases and immunoRNases as anticancer drugs. (2009) (28)
- Screening of molecular repertoires by microbial surface display. (2005) (28)
- Cytosolic delivery of macromolecules in live human cells using the combined endosomal escape activities of a small molecule and cell penetrating peptides. (2019) (28)
- Phage display-based identification and potential diagnostic application of novel antigens from Mycoplasma mycoides subsp. mycoides small colony type. (2010) (26)
- Production of single chain Fab (scFab) fragments in Bacillus megaterium (2007) (26)
- Suppression of p75 Neurotrophin Receptor Surface Expression with Intrabodies Influences Bcl-xL mRNA Expression and Neurite Outgrowth in PC12 Cells (2012) (26)
- Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy (2021) (26)
- Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases (2020) (25)
- Human-like antibodies neutralizing Western equine encephalitis virus (2014) (25)
- Antibody production in Bacillus megaterium: strategies and physiological implications of scaling from microtiter plates to industrial bioreactors. (2011) (24)
- Regulated secretion and purification of recombinant antibodies inE. coli (1992) (24)
- Functional knockdown of VCAM-1 at the posttranslational level with ER retained antibodies. (2009) (24)
- Construction of human naive antibody gene libraries. (2012) (23)
- New anti-CD30 human pancreatic ribonuclease-based immunotoxin reveals strong and specific cytotoxicity in vivo (2007) (23)
- Baculovirus-free insect cell expression system for high yield antibody and antigen production (2020) (23)
- A single-chain TNF receptor antagonist is an effective inhibitor of TNF mediated cytotoxicity. (1995) (23)
- Human antibody libraries in Escherichia coli. (1995) (22)
- Modeling Neurodegenerative Spinocerebellar Ataxia Type 13 in Zebrafish Using a Purkinje Neuron Specific Tunable Coexpression System (2019) (22)
- Production of single chain fragment variable (scFv) antibodies in Escherichia coli using the LEX™ bioreactor. (2013) (22)
- Functional roles of Cav1.3, Cav3.1 and HCN channels in automaticity of mouse atrioventricular cells (2011) (21)
- Thiophilic adsorption chromatography of recombinant single-chain antibody fragments. (1994) (20)
- Head activator acts as an autocrine growth factor for NH15‐CA2 cells in the G2/mitosis transition. (1989) (19)
- Animal-derived-antibody generation faces strict reform in accordance with European Union policy on animal use (2020) (19)
- Analysis of Single Chain Antibody Sequences Using the VBASE2 Fab Analysis Tool (2010) (19)
- Functional knock down of VCAM1 in mice mediated by endoplasmatic reticulum retained intrabodies (2014) (19)
- Identification of a new epitope for HIV‐neutralizing antibodies in the gp41 membrane proximal external region by an Env‐tailored phage display library (2013) (18)
- Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis – impact of radiochemistry on pharmacokinetics (2018) (18)
- Fine mapping of the antigen–antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster (1999) (18)
- Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy. (2008) (18)
- Hyperphage. Improving antibody presentation in phage display. (2003) (18)
- Rapid titration of multiple samples of filamentous bacteriophage (M13) on nitrocellulose filters. (2000) (18)
- Production of monoclonal antibodies against epitopes of the main coat protein of filamentous fd phages. (1994) (18)
- Targeted therapeutic RNases (ImmunoRNases). (2009) (17)
- Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV (2017) (17)
- Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B (2014) (17)
- Influence of the hydromechanical stress and temperature on growth and antibody fragment production with Bacillus megaterium (2011) (17)
- Cell surface display of a single-chain antibody for attaching polypeptides. (1996) (16)
- Development of Neutralizing and Non-neutralizing Antibodies Targeting Known and Novel Epitopes of TcdB of Clostridioides difficile (2018) (15)
- Oligomeric forms of single chain immunoglobulin (scIgG) (2010) (15)
- Reproducibility: bypass animals for antibody production (2020) (14)
- Mining gut microbiome oligopeptides by functional metaproteome display (2016) (14)
- Analysis of protein interactions with immobilized Peptide arrays synthesized on membrane supports. (2006) (14)
- Primary structure and functional scFv antibody expression of an antibody against the human protooncogen c-myc. (1997) (14)
- Epitopes fused to F-pilin are incorporated into functional recombinant pili. (1998) (13)
- Handbook of therapeutic antibodies : technologies, emerging developments and approved therapeutics (2010) (13)
- Microtubule-dependent cell cycle regulation is implicated in the G2 phase of Hydra cells. (1988) (12)
- Structural differences of amyloid-β fibrils revealed by antibodies from phage display (2015) (12)
- Comprar Handbook of Therapeutic Antibodies | Stefan Dübel | 9783527314539 | Wiley (2007) (12)
- A strategy to identify linker-based modules for the allosteric regulation of antibody-antigen binding affinities of different scFvs (2017) (12)
- Surface display of antibodies. (1994) (12)
- Utilisation of antibody microarrays for the selection of specific and informative antibodies from recombinant library binders of unknown quality. (2016) (12)
- Low-cost, in-liquid measuring system using a novel compact oscillation circuit and quartz-crystal microbalances (QCMs) as a versatile biosensor platform (2017) (12)
- Embryonic zebrafish primary cell culture for transfection and live cellular and subcellular imaging. (2017) (12)
- Recent Advances with ER Targeted Intrabodies. (2016) (12)
- Recombinant antibody fragments allow repeated measurements of C-reactive protein with a quartz crystal microbalance immunosensor (2013) (11)
- Corrigendum: ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome (2007) (11)
- Recombinant variants of antibody 138H11 against human gamma-glutamyltransferase for targeting renal cell carcinoma. (2006) (11)
- Mutations in the N-Terminus of the Major Coat Protein (pVIII, gp8) of Filamentous Bacteriophage Affect Infectivity (2003) (11)
- Human antibodies targeting CD30(+) lymphomas. (2012) (10)
- A SARS-CoV-2 Neutralizing Antibody Selected from COVID-19 Patients by Phage Display is Binding to the ACE2-RBD Interface and is Tolerant to Known RBD Mutations (2020) (10)
- Sequence defined antibodies improve the detection of cadherin 2 (N-cadherin) during zebrafish development. (2017) (10)
- Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines (1995) (10)
- Terminal differentiation of head- and foot-specific epithelial cells occurs at the same location in Hydra tissue without polarity. (1990) (10)
- Cloning and Expression of Single-Chain Fragments (scFv) from Mouse and Rat Hybridomas. (1998) (10)
- Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis (2021) (9)
- Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platform (2014) (9)
- Analysis of Protein Interactions Using a Quartz Crystal Microbalance Biosensor (2002) (9)
- Generation of a human IgM expression library in E. coli (1992) (9)
- Pyruvate dehydrogenase complex—enzyme 2, a new target for Listeria spp. detection identified using combined phage display technologies (2020) (8)
- Single Chain Antibodies as Tools to Study transforming growth factor-β-Regulated SMAD Proteins in Proximity Ligation-Based Pharmacological Screens* (2016) (8)
- Evaluating the Delivery of Proteins to the Cytosol of Mammalian Cells. (2017) (8)
- Characterization of haploid acetabularia cells (1985) (8)
- Therapeutic Antibodies ‐ from Past to Future (2014) (8)
- Protein stabilization through phage display (2000) (8)
- A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients by phage display is binding to the ACE2-RBD interface and is tolerant to most known recently emerging RBD mutations (2020) (8)
- Directed evolution of super-secreted variants from phage-displayed human Interleukin-2 (2019) (8)
- Construction of scFv from Hybridoma by Two-Step Cloning (2001) (8)
- Human Anti-Lipopolysaccharid (LPS) antibodies against Legionella with high species specificity. (2017) (8)
- Selection Strategies II: Antibody Phage Display (2008) (8)
- Structural insights into antigen recognition of an anti-β-(1,6)-β-(1,3)-D-glucan antibody (2018) (7)
- Affinity-matured variants derived from nimotuzumab keep the original fine specificity and exhibit superior biological activity (2020) (7)
- Cloning of Variable Domains from Mouse Hybridoma by PCR (2010) (7)
- Human Antibody Gene Libraries (2010) (7)
- ORFeome Phage Display. (2018) (7)
- Animal- versus in vitro-derived antibodies: avoiding the extremes (2021) (7)
- Handbook of Therapeutic Antibodies: Dübel/Handbook of Therapeutic Antibodies (2014) (7)
- Selection of recombinant antibodies from antibody gene libraries. (2014) (7)
- Universal antibody libraries on phage and bacteria. (1993) (6)
- Primary structure of the antigen-binding domains of a human oligodendrocyte-reactive IgM monoclonal antibody derived from a patient with multiple sclerosis (1999) (6)
- Anti-ErbB2 Monoclonal Antibodies : by Tumor Inhibitory and Stimulatory Identification of Epitope Regions Recognized (2001) (6)
- The "sneaking-ligand" approach: cell-type specific inhibition of the classical NF-κB pathway. (2015) (5)
- Recombinant human monoclonal antibodies. Basic principles of the immune system transferred to E. coli. (1992) (5)
- Antibody Phage Display (2014) (5)
- Recombinant human monoclonal antibodies (1992) (5)
- Generation of Recombinant Antibodies against the beta-(1,6)-Branched beta-(1,3)-D-Glucan Schizophyllan from Immunized Mice via Phage Display (2017) (5)
- Primary structure and functional expression of heavy- and light-chain variable region genes of a monoclonal antibody specific for human fibrin. (1997) (4)
- Recent developments in antibody engineering. (1998) (4)
- Generation of Antibody Gene Libraries from Seropositive Human Donors (2001) (3)
- Antibody fusion proteins with human ribonucleases 1 to 8. (2018) (3)
- The antibody web (2000) (3)
- Culture and Transfection of Zebrafish Primary Cells. (2018) (3)
- Improving Phage Display Throughput by Using Hyperphage, Miniaturized Titration and pVIII (g8p) ELISA (2010) (3)
- Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment (2022) (2)
- Production of Recombinant Human IgG Antibodies in the Baculovirus Expression System (2001) (2)
- Funktionales Proteom-Display zur Identifikation von Biomarkern (2016) (2)
- Rekombinante Antikörper: Werkzeuge gegen Krebs, Infektionen und Autoimmunerkrankungen? (2004) (2)
- Phage Display-Derived Monoclonal Antibodies Against Internalins A and B Allow Specific Detection of Listeria monocytogenes (2022) (2)
- Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19 (2020) (2)
- Proteomics' framework for success? (2007) (2)
- Antibody Engineering (2010) (2)
- Rekombinante Antikörper (2019) (2)
- The sneaking ligand approach for cell type-specific modulation of intracellular signalling pathways. (2017) (2)
- Functional Minipreps of scFv-Antibody Fragments (2001) (1)
- A single chain antibody obtained by cell panning of antibody phage inhibits homoaggregation of human leukemia cells. (2005) (1)
- A Tissue-specific NF-κB inhibitor ameliorates inflammatory joint diseases (2010) (1)
- Is There an End in Sight for Animal Testing ? Can Organ-ona-Chip Replace Animal Use in Safety Testing with Advanced Human-focused Approaches ? (2019) (1)
- Antibody reproducibility challenges: the solution lies in the sequence (2016) (1)
- Affinity Measurements of Antibody Fragments on Phage by Quartz Crystal Microbalance (QCM) (2001) (1)
- Itolizumab (Alzumab), Mogamulizumab (Poteligeo), and Tositumomab (Bexxar) (2014) (1)
- COR-101, ein menschlicher Antikörper gegen COVID-19 (2021) (1)
- Antibody Production: Human, Recombinant (2010) (1)
- Multiklonale Antikörper als Ersatz für Zweitantikörper aus Seren (2020) (1)
- Parallelized Microscale Expression of Soluble scFv. (2019) (1)
- Control of Morphogenesis by Nervous System-derived Factors (1989) (1)
- ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein (2022) (1)
- Viele monoklonale Antikörper sind nicht monospezifisch (2018) (1)
- Programming antibodies for novel applications (2018) (0)
- Approved therapeutic antibodies and in vivo diagnostics (2014) (0)
- Heterogeneous Detection of PCR-Amplified Intimin Gene From E. Coli O157:H7 via PDMS Microfluidic Chip (2009) (0)
- Trendbericht Biochemie 2017: Menschliche Antikörper für Medikamente (2018) (0)
- Viele monoklonale Antikörper sind nicht monospezifisch (2018) (0)
- Was sind Antikörper und wie funktionieren sie? (2019) (0)
- Anwendungsgebiete für rekombinante Antikörper (2019) (0)
- Anticorps anti-muc1 de recombinaison (2009) (0)
- Schlüsselreagenzien für die Proteomforschung im Hochdurchsatz (2007) (0)
- Wie werden rekombinante Antikörper produziert und aufgereinigt (2019) (0)
- Ustekinumab (Stelara®1)2 (2014) (0)
- Wie werden rekombinante Antikörper generiert und charakterisiert? (2019) (0)
- Funktionales Proteom-Display zur Identifikation von Biomarkern (2016) (0)
- Antikörper-Engineering: Maßgeschneiderte Reagenzien für jede Anwendung (2019) (0)
- Die Antikörperfabrik: Antikörper für jedes Protein (2007) (0)
- COR-101, ein menschlicher Antikörper gegen COVID-19 (2021) (0)
- Neue Impulse für den Protein-Knock-down mit intrabodies (2016) (0)
- Rekombinante, vollständig humane Antikörper zur Behandlung akuter COVID-19 (2020) (0)
- Rekombinante anti-MUC1-Antikörper (2008) (0)
- Multiklonale Antikörper als Ersatz für Zweitantikörper aus Seren (2020) (0)
- Anti-ricin-antikörper (2008) (0)
- Anticorps de recombinaison trivalents a regions variables stabilisees par des ponts disulfure (2001) (0)
- Crystal structure of antibody against schizophyllan (2018) (0)
- Implications for Vaccine Design Anti-ErbB-2 Monoclonal Antibodies: by Tumor Inhibitory and Stimulatory Identification of Epitope Regions Recognized (2001) (0)
- Investigation of Conditions for Capture of Live Legionella pneumophila with Polyclonal and Recombinant Antibodies (2022) (0)
- Plant Defense Proteins as Potential Markers for Early Detection of Forest Damage and Diseases (2021) (0)
- Trivalente antikörperkonstrukte mit disulfid-brücken stabilisierten variablen regionen (2001) (0)
- Abciximab, Arcitumomab, Basiliximab, Capromab, Cotara, Daclizumab, Edrecolomab, Ibritumomab, Igovomab, Nofetumomab, Satumomab, Sulesomab, Tositumomab, and Votumumab (2008) (0)
- Reproducibility: bypass animals for antibody production (2020) (0)
- Bindungsreagens für Zell-Oberflächenprotein und Effektorzelle (1994) (0)
- 1 Therapeutic Antibodies – from Past to Future (2014) (0)
- Development of an inhibiting antibody against equine interleukin 5 to treat insect bite hypersensitivity of horses (2023) (0)
- Year : 2007 Single chain Fab ( scFab ) fragment (2007) (0)
- Using the power of in vitro selection by phage display to identify recombinant antibodies with optimised properties to various life threatening viruses (2011) (0)
- Neue Impulse für den Protein-Knock-down mit intrabodies (2016) (0)
- Development of Human and Macaque Antibodies Using Antibody Phage Display for the Detection of Equine Encephalitis Viruses (2011) (0)
- Directed evolution of super-secreted variants from phage-displayed human Interleukin-2 (2019) (0)
- Production and utilization genebank human antibody ( "human antibody libraries"). (1991) (0)
- Cell-free synthesis of functional antibodies using a coupled in vitro transcription-translation system based on CHO cell lysates (2017) (0)
- Sneaking ligands inhibiting NF-kappaB activation selectively in endothelial cells improve experimental arthritides (2017) (0)
- In vitro evolution of myc-tag antibodies: in-depth specificity and affinity analysis of Myc1-9E10 and Hyper-Myc (2022) (0)
- Affinity-matured variants derived from nimotuzumab keep the original fine specificity and exhibit superior biological activity (2020) (0)
- Process for the preparation of human antibody gene banks ( "human antibody libraries") (1991) (0)
- Shelf-Life Extension of Fc-Fused Single Chain Fragment Variable Antibodies by Lyophilization (2021) (0)
- Structural insights into antigen recognition of an anti-β-(1,6)-β-(1,3)-D-glucan antibody (2018) (0)
- Correlation between Mycobacterium avium ssp . paratuberculosis infection and colitis (2014) (0)
- Generation of HIV 1 envelope immunogens with enhanced bnAB binding and reduced CD 4 binding using a FACS based high throughput mapping platform (2015) (0)
- Selection of a macaque scFv with human-like framework regions, nanomolar affinity, and that neutralizes the lethal factor (LF) of Bacillus anthracis in vitro and in vivo, by inhibiting the PA/LF complex formation (2007) (0)
- Functional knockdown of surface VCAM-1 at the posttranslational level with ER-retained antibodies (2009) (0)
- Ginotecas preparation and use of human antibodies ( "human antibody banks"). (1991) (0)
- Chapter 2 Recombinant Antibodies and In Vitro Selection Technologies (2012) (0)
- Antibody Phage Display Libraries for Use in Therapeutic Gene Targeting (2003) (0)
- Comprar Antibody engineering vol. 1 | Kontermann, Roland | 9783642011436 | Springer (2010) (0)
- Chemiegeschichte: Vom Gen zum Produkt (2022) (0)
This paper list is powered by the following services:
Other Resources About Stefan Dübel
What Schools Are Affiliated With Stefan Dübel?
Stefan Dübel is affiliated with the following schools:
